Ethyl pyruvate administration suppresses growth and invasion of gallbladder cancer cells via downregulation of HMGB1-RAGE axis

International Journal of Immunopathology and Pharmacology

Volumn 25, Issue 4, 2012, Pages 955-965

  Li, M L ^a   Wang, X F ^a   Tan, Z J ^a   Dong, P ^a   Gu, J ^a   Lu, J H ^a   Wu, X S ^a   Zhang, L ^a   Ding, Q C ^a   Wu, W G ^a   Rao, L H ^a   Mu, J S ^a   Yang, J H ^a   Weng, H ^a   Ding, Q ^a   Zhang, W J ^a   Chen, L ^a   Liu, Ying Bin ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Ethyl pyruvate; Gallbladder cancer; Growth; HMGB1; Invasion; RAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; HIGH MOBILITY GROUP B1 PROTEIN; PYRUVIC ACID DERIVATIVE; PYRUVIC ACID ETHYL ESTER; UNCLASSIFIED DRUG; ADVANCED GLYCATION END PRODUCT; ANTINEOPLASTIC AGENT; COLLAGEN TYPE 4; CYCLINE; ETHYL PYRUVATE; GELATINASE B; LAMININ; MESSENGER RNA; PROTEIN P53;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE S PHASE; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); DOWN REGULATION; GALLBLADDER CANCER; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING; BASEMENT MEMBRANE; CANCER GROWTH; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL GROWTH; CELL INVASION; CELLULAR DISTRIBUTION; COLONY FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; GALLBLADDER CANCER CELL LINE; GENETIC TRANSCRIPTION; PROTEIN ANALYSIS; S PHASE CELL CYCLE CHECKPOINT; SIGNAL TRANSDUCTION; TUMOR INVASION; UPREGULATION;

EID: 84872939937     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201202500413     Document Type: Article

References (30)

1. Lotze MT, DeMarco RA. Dealing with death: HMGB1 as a novel target for cancer therapy. Curr Opin Investig Drugs 2003; 4:1405-9.
2. Dumitriu IE, Baruah P, Valentinis B, et al. Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. J Immunol 2005; 174:7506-15.
3. Sasahira T, Akama Y, Fujii K, Kuniyasu H. Expression of receptor for advanced glycation end products and HMGB1/amphoterin in colorectal adenomas. Virchows Arch 2005; 446:411-5.
4. Han SH, Kim YH, Mook-Jung I. RAGE: the beneficial and deleterious effects by diverse mechanisms of actions. Mol Cells 2011; 31:91-7.
5. Kuniyasu H, Oue N, Wakikawa A, et al. Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer. J Pathol 2002; 196:163-70.
6. Allmen EU, Koch M, Fritz G, Legier DF. V domain of RAGE interacts with AGEs on prostate carcinoma cells. Prostate 2008; 68:748-58.
7. Sasahira T, Kirita T, Bhawal UK, Ikeda M, Nagasawa A, Yamamoto K, Kuniyasu H. The expression of receptor for advanced glycation end products is associated with angiogenesis in human oral squamous cell carcinoma. Virchows Arch 2007; 450:287-95.
8. Lin L, Zhong K, Sun Z, Wu G, Ding G. Receptor for advanced glycation end products (RAGE) partially mediates HMGB1-ERKs activation in clear cell renal cell carcinoma. J Cancer Res Clin Oncol 2012; 138:11-22.
9. Alexiou P, Chatzopoulou M, Pegklidou K, Demopoulos VJ. RAGE: a multi-ligand receptor unveiling novel insights in health and disease. Curr Chem 2010; 17:2232-52.
10. Das UN. Pyruvate is an endogenous antiinflammatory and anti-oxidant molecule. Med Sci Monit 2006; 12:RA79-84.
11. Lim SC, Choi JE, Kim CH, Duong HQ, Jeong GA, Kang HS, Han SI. Ethyl pyruvate induces necrosis-to-apoptosis switch and inhibits high mobility group box protein 1 release in A549 lung adenocarcinoma cells. Int J Mol Med 2007; 20:187-92.
12. Hirata K, Takada M, Suzuki Y, Kuroda Y. Expression of receptor for advanced glycation end products (RAGE) in human biliary cancer cells. Hepatogastroenterology 2003; 50:1205-7.
13. Tan Z, Li M, Wu W, Zhang L, Ding Q, Wu X, Mu J, Liu Y. NLK is a key regulator of proliferation and migration in gallbladder carcinoma cells. Mol Cell Biochem 2012; 369:27-33.
14. Wang J, Peng S, Liu J, et al. Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1. Cancer Letters 2009; 281:71-81.
15. Quan Z, Gu J, Dong P, et al. Reactive oxygen species-mediated endoplasmic reticulum stress and mitochondrial dysfunction contribute to cirsimaritin-induced apoptosis in human gallbladder carcinoma GBC-SD cells. Cancer Lett 2010; 295:252-9.
16. Dong P, Zhang Y, Gu J, et al. Wogonin, an active ingredient of Chinese herb medicine Scutellaria baicalensis, inhibits the mobility and invasion of human gallbladder carcinoma GBC-SD cells by inducing the expression of maspin. J Ethnopharmacol 2011; 137:1373-80.
17. Zhang Z, Wang X, Wu W, et al. Effects of matrine on proliferation and apoptosis in gallbladder carcinoma cells (GBC-SD). Phytother Res 2012; 26:932-7.
18. Todorova J, Pasheva E. High mobility group B1 protein interacts with its receptor RAGE in tumor cells but not in normal tissues. Oncol Lett 2012; 3:214-8.
19. Sparatore B, Pedrazzi M, Passalacqua M, Gaggero D, Patrone M, Pontremoli S, Melloni E. Stimulation of erythroleukaemia cell differentiation by extracellular high-mobility group-box protein 1 is independent of the receptor for advanced glycation end-products. Biochem J 2002; 363:529-35.
20. Kuniyasu H, Yano S, Sasaki T, Sasahira T, Sone S, Ohmori H. Colon cancer cell-derived high mobility group 1/amphoterin induces growth inhibition and apoptosis in macrophages. Am J Pathol 2005; 166:751-60.
21. Riuzzi F, Sorci G, Donato R. The amphoterin (HMGB 1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in vivo. J Biol Chem 2006; 281:8242-53.
22. Liang X, Chavez AR, Schapiro NE, et al. Ethyl pyruvate administration inhibits hepatic tumor growth. J Leukoc Biol 2009; 86:599-607.
23. Muller AJ, DuHadaway JB, Jailer D, Curtis P, Metz R, Prendergast GC. Immunotherapeutic suppression of indoleamine 2,3-dioxygenase and tumor growth with ethyl pyruvate. Cancer Res 2010; 70:1845-53.
24. Zhang J, Zhu J-S, Zhou Z, et al. Therapeutic effects of ethyl pyruvate on tumor growth and metastasis in a severe combined immunodeficiency mouse orthotopic implantation model. Eur J Inflamm 2012; 10:25-32.
25. Hanada K, Itoh M, Fujii K, Tsuchida A, Ishimaru S, Hirata M, Kajiyama G. Expression of the proliferative cell nuclear antigen (PCNA) in adenocarcinoma of the gallbladder, and its relationship to prognosis. Scand J Clin Lab Invest 1995; 55:377-82.
26. Karadag N, Kirimlioglu H, Isik B, Yilmaz S, Kirimlioglu V. Expression of matrix metalloproteinases in gallbladder carcinoma and their significance in carcinogenesis. Appl Immunohistochem Mol Morphol 2008; 16:148-52.
27. Vaseva AV and Moll UM. The mitochondrial p53 pathway. Biochim Biophys Acta 2009; 1787:414-20.
28. Kang R, Tang D, Schapiro NE, et al. The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival. Cell Death Differ 2010; 17:666-76.
29. Takada M, Hirata K, Ajiki T, Suzuki Y, Kuroda Y. Expression of receptor for advanced glycation end products (RAGE) and MMP-9 in human pancreatic cancer cells. Hepatogastroenterology 2004; 51:928-30.
30. Zhang J, Zhu JS, Zhou Z, Chen WX, Chen NW. Inhibitory effects of ethyl pyruvate administration on human gastric cancer growth via regulation of the HMGB1-RAGE and Akt pathways in vitro and in vivo. Oncol Rep 2012; 27:1511-9.